Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/Lemborexant> ?p ?o }
Showing triples 1 to 74 of
74
with 100 triples per page.
- Lemborexant abstract "Lemborexant (INN) (code name E-2006) is a dual antagonist of the orexin OX1 and OX2 receptors which is under development by Eisai for the treatment of insomnia. As of December 2014, it is in phase II clinical trials.".
- Lemborexant atcPrefix "None".
- Lemborexant casNumber "1369764-02-2".
- Lemborexant iupacName "(1R,2S)-2-[(2,4-dimethylpyrimidin-5-yl)oxymethyl]-2-(3-fluorophenyl)-N-(5-fluoropyridin-2-yl)cyclopropane-1-carboxamide".
- Lemborexant pubchem "56944144".
- Lemborexant thumbnail Lemborexant.svg?width=300.
- Lemborexant wikiPageExternalLink 800035210.
- Lemborexant wikiPageID "46784047".
- Lemborexant wikiPageLength "3390".
- Lemborexant wikiPageOutDegree "22".
- Lemborexant wikiPageRevisionID "665315943".
- Lemborexant wikiPageWikiLink Almorexant.
- Lemborexant wikiPageWikiLink Category:Carboxamides.
- Lemborexant wikiPageWikiLink Category:Hypnotics.
- Lemborexant wikiPageWikiLink Category:Orexin_antagonists.
- Lemborexant wikiPageWikiLink Category:Organofluorides.
- Lemborexant wikiPageWikiLink Category:Pyridines.
- Lemborexant wikiPageWikiLink Category:Pyrimidines.
- Lemborexant wikiPageWikiLink Clinical_trial.
- Lemborexant wikiPageWikiLink Eisai_(company).
- Lemborexant wikiPageWikiLink Filorexant.
- Lemborexant wikiPageWikiLink Hypocretin_(orexin)_receptor_1.
- Lemborexant wikiPageWikiLink Hypocretin_(orexin)_receptor_2.
- Lemborexant wikiPageWikiLink Insomnia.
- Lemborexant wikiPageWikiLink International_nonproprietary_name.
- Lemborexant wikiPageWikiLink MIN-202.
- Lemborexant wikiPageWikiLink Orexin.
- Lemborexant wikiPageWikiLink Orexin_antagonist.
- Lemborexant wikiPageWikiLink Orexin_receptor.
- Lemborexant wikiPageWikiLink Phases_of_clinical_research.
- Lemborexant wikiPageWikiLink SB-649,868.
- Lemborexant wikiPageWikiLink Suvorexant.
- Lemborexant wikiPageWikiLinkText "Lemborexant".
- Lemborexant atcPrefix "None".
- Lemborexant c "22".
- Lemborexant casNumber "1369764".
- Lemborexant chemspiderid "34500836".
- Lemborexant f "2".
- Lemborexant h "20".
- Lemborexant inchi "InChI=1S/C22H20F2N4O2/c1-13-1930-12-229-182128-20-7-6-1710-26-20/h3-8,10-11,18H,9,12H2,1-2H3,/t18-,22+/m0/s1".
- Lemborexant inchikey "MUGXRYIUWFITCP-PGRDOPGGSA-N".
- Lemborexant iupacName "-2".
- Lemborexant legalStatus "experimental drug".
- Lemborexant molecularWeight "410.417".
- Lemborexant n "4".
- Lemborexant o "2".
- Lemborexant pubchem "56944144".
- Lemborexant smiles "CC1=NCC".
- Lemborexant width "175".
- Lemborexant wikiPageUsesTemplate Template:Drugbox.
- Lemborexant wikiPageUsesTemplate Template:Insomnia_pharmacotherapies.
- Lemborexant wikiPageUsesTemplate Template:Nervous-system-drug-stub.
- Lemborexant wikiPageUsesTemplate Template:Neuropeptidergics.
- Lemborexant wikiPageUsesTemplate Template:Reflist.
- Lemborexant subject Category:Carboxamides.
- Lemborexant subject Category:Hypnotics.
- Lemborexant subject Category:Orexin_antagonists.
- Lemborexant subject Category:Organofluorides.
- Lemborexant subject Category:Pyridines.
- Lemborexant subject Category:Pyrimidines.
- Lemborexant hypernym Antagonist.
- Lemborexant type ChemicalSubstance.
- Lemborexant type Drug.
- Lemborexant type ChemicalObject.
- Lemborexant type Thing.
- Lemborexant type Q8386.
- Lemborexant comment "Lemborexant (INN) (code name E-2006) is a dual antagonist of the orexin OX1 and OX2 receptors which is under development by Eisai for the treatment of insomnia. As of December 2014, it is in phase II clinical trials.".
- Lemborexant label "Lemborexant".
- Lemborexant sameAs Q20707990.
- Lemborexant sameAs m.0138xv0p.
- Lemborexant sameAs Q20707990.
- Lemborexant wasDerivedFrom Lemborexant?oldid=665315943.
- Lemborexant depiction Lemborexant.svg.
- Lemborexant isPrimaryTopicOf Lemborexant.